<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756594794</udiDi>
    <basicUdiDi>B-05944756594794</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1636</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:33.788Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594787</udiDi>
    <basicUdiDi>B-05944756594787</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1635</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:32.995Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594770</udiDi>
    <basicUdiDi>B-05944756594770</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1634</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:28.972Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594763</udiDi>
    <basicUdiDi>B-05944756594763</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1633</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:28.175Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594756</udiDi>
    <basicUdiDi>B-05944756594756</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1632</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:27.372Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594732</udiDi>
    <basicUdiDi>B-05944756594732</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1630</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:22.566Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594725</udiDi>
    <basicUdiDi>B-05944756594725</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1629</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:21.764Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594718</udiDi>
    <basicUdiDi>B-05944756594718</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1628</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:20.989Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594701</udiDi>
    <basicUdiDi>B-05944756594701</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1627</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:20.180Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594695</udiDi>
    <basicUdiDi>B-05944756594695</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1626</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:16.164Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594688</udiDi>
    <basicUdiDi>B-05944756594688</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1625</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:15.361Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594671</udiDi>
    <basicUdiDi>B-05944756594671</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1624</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:14.562Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594664</udiDi>
    <basicUdiDi>B-05944756594664</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1623</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:13.761Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594657</udiDi>
    <basicUdiDi>B-05944756594657</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1622</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:09.755Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594640</udiDi>
    <basicUdiDi>B-05944756594640</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1621</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:09.698Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594626</udiDi>
    <basicUdiDi>B-05944756594626</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1619</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:09.661Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594619</udiDi>
    <basicUdiDi>B-05944756594619</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1618</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:04.929Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594602</udiDi>
    <basicUdiDi>B-05944756594602</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1617</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:02.526Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594596</udiDi>
    <basicUdiDi>B-05944756594596</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1616</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:00.928Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594589</udiDi>
    <basicUdiDi>B-05944756594589</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1615</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:00.128Z</lastUpdated>
  </row>
</eudamedExport>